Evidence map›Paper›PMID 28082379›Full record

Trial reportBMJ (Clinical research ed.)2017

Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis: randomised, superiority, parallel group trial in Denmark (OPUS II).

Nikolai Albert, Marianne Melau, Heidi Jensen, Charlotte Emborg, Jens Richardt Mollegaard Jepsen, Birgitte Fagerlund, Christian Gluud, Ole Mors, Carsten Hjorthøj, Merete Nordentoft

Erratum issued Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT00914238 (A Randomized Clinical Trial of the Effect of Five-years Versus Two-years Specialized Assertive Intervention for First Episode Psychosis - the OPUS II Trial), which is not on this map. Cited by 39 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 5 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00914238 nacompletednot on this map

A Randomized Clinical Trial of the Effect of Five-years Versus Two-years Specialized Assertive Intervention for First Episode Psychosis - the OPUS II Trial

TypeinterventionalSponsorUniversity of CopenhagenRan2009 to 2016Enrolled400ConditionsFirst Episode Psychosis of Schizophrenia and Schizotypal Disorder, Psychotic Disorders, Schizophrenia, Schizoaffective DisorderArms2 years OPUS treatment, OPUS 5 years
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.European psychiatry : the journal of the Association of European Psychiatrists · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Specialised early intervention teams for recent-onset psychosis.The Cochrane database of systematic reviews · 2020
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Suicidality Over the First 5 Years of Psychosis: Does Extending Early Intervention Have Benefits?Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2021
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Nikolai AlbertCopenhagen University Hospital, Mental Health Centre Copenhagen, Research Unit, Hellerup, Denmark Nikolai.albert@regionh.dk.
Marianne MelauCopenhagen University Hospital, Mental Health Centre Copenhagen, Research Unit, Hellerup, Denmark.
Heidi JensenCopenhagen University Hospital, Mental Health Centre Copenhagen, Research Unit, Hellerup, Denmark.
Charlotte EmborgPsychosis Ward, Section P, Aarhus University Hospital, Risskov, Denmark.
Jens Richardt Mollegaard JepsenCentre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Glostrup, Denmark.
Birgitte FagerlundCentre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Glostrup, Denmark.
Christian GluudCopenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Ole MorsPsychosis Research Unit, Aarhus University Hospital, Risskov, Risskov, Denmark.
Carsten HjorthøjCopenhagen University Hospital, Mental Health Centre Copenhagen, Research Unit, Hellerup, Denmark.
Merete NordentoftCopenhagen University Hospital, Mental Health Centre Copenhagen, Research Unit, Hellerup, Denmark.
Copenhagen University Hospital · DKAarhus University Hospital · DKGlostrup Hospital · DKRigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the effects of five years of specialised early intervention (SEI) treatment for first episode schizophrenia spectrum disorder with the standard two years of SEI plus three years of treatment as usual.

designRandomised, superiority, parallel group trial with blinded outcome assessment. Randomisation was centralised and computerised with concealed randomisation sequence carried out at an external site.

settingParticipants were recruited from six OPUS teams in Denmark between 2009 and 2012. OPUS teams provide SEI treatment to all patients diagnosed with a schizophrenia spectrum disorder in Denmark.

participants400 participants (51% women) with a mean age of 25.6 (standard deviation 4.3) were randomised to five years of SEI (experimental intervention; n=197) or to two years of SEI plus three years of treatment as usual (control; n=203).

interventionsOPUS treatment consists of three core elements-modified assertive community treatment, family involvement, and social skill training-with a patient-case manager ratio of no more than 12:1. For participants randomised to five years of OPUS treatment, the treatment was largely unchanged. Participants randomised to the control group were mostly referred to community health centres after two years of SEI treatment. MAIN OUTCOMES: Follow-up assessments were conducted five years after start of OPUS treatment. Primary outcome was negative symptoms measured on the scale for assessment of negative symptoms (avolition-apathy, anhedonia, alogia, and affective blunting). Secondary outcomes were remission of both negative and psychotic symptoms, psychotic symptoms, suicidal ideation, substance abuse, compliance with medical treatment, adherence with treatment, client satisfaction, days in hospital care, and labour market affiliation.

resultsLevels of negative symptoms did not differ between the intervention group and control group (1.72 v 1.81 points; estimated mean difference -0.10 (95% confidence interval -0.33 to 0.13), P=0.39). Participants receiving five years of OPUS treatment were more likely to remain in contact with specialised mental health services (90.4% v 55.6%, P<0.001), had higher client satisfaction (estimated mean difference 2.57 points (95% confidence interval 1.36 to 3.79), P<0.001), and had a stronger working alliance (estimated mean difference 5.56 points (95% confidence interval 2.30 to 8.82), P=0.001) than the control group.

conclusionsThis trial tests SEI treatment for up to five years for patients with first episode schizophrenia spectrum disorder; previous trials have found treatment effects for programmes lasting from one to three years. The prolonged SEI treatment had few effects, which could be due to the high level of treatment provided to control participants and the late start of specialised treatment.Trial registration Clinicaltrial.gov NCT00914238.

Indexed as

Early Medical InterventionAdolescentAdultAntipsychotic AgentsBehavior TherapyCommunity Mental Health ServicesDenmarkFamilyFemaleHumansMaleSchizophreniaSocial SkillsYoung AdultAntipsychotic Agents

Identifiers

PMID28082379
PMCPMC5228538
OpenAlexW2575993438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.